Prenatal screening for Down syndrome and neural tube defects in twin pregnancies

Prenatal Diagnosis

Volumn 25, Issue 9, 2005, Pages 740-745

  Wald, Nicholas J ^a   Rish, Simon ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Logical Medical Systems   (United Kingdom)

Author keywords

Down syndrome; Neural tube defect; Prenatal screening; Twin pregnancy

Indexed keywords

ALPHA FETOPROTEIN;

DOWN SYNDROME; FACIAL BONE; HEALTH PRACTITIONER; HUMAN; MATHEMATICAL ANALYSIS; NEURAL TUBE DEFECT; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; TWIN PREGNANCY;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; NECK; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY TRIMESTERS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; TWINS; ULTRASONOGRAPHY, PRENATAL;

EID: 26044466046     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1258     Document Type: Review

References (27)

1. Bersinger NA, Noble P, Nicolaides KH. 2003. First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies. Prenat Diagn 23: 157-162.
2. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. 2001. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 358: 1665-1667.
3. Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides KH. 2004. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan. Ultrasound Obstet Gynecol 23: 218-223.
4. Cuckle H. 1998. Down's syndrome screening in twins. J Med Screen 5: 3-4.
5. Cuckle H, Wald N, Stevenson JD, et al. 1990. Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies. Prenat Diagn 10: 71-77.
6. Evans MI, Goldberg JD, Horenstein R, et al. 1999. Selective termination for structural chromosomal and Mendelian anomalies: international experience. Am J Obstet Gynecol 181: 893-897.
7. Morris JK, Mutton DE, Alberman E. 2002. Revised estimates of the maternal age-specific live birth prevalence of Down's syndrome. J Med Screen 9: 2-6.
8. Muller F, Dreux S, Dupoizat H, et al. 2003. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity. Prenat Diagn 23: 331-335.
9. Neveux LM, Palomaki GE, Knight GJ, Haddow JE. 1996. Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn 16: 29-34.
10. Nicolaides KH, Snijders RJM, Cuckle HS. 1998. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 18: 519-523.
11. Niemimaa M, Suonpaa M, Heinonen S, Seppala M, Bloigu R, Ryynanen M. 2002. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester. Prenat Diagn 22: 183-185.
12. Noble PL, Snijders RJM, Abraha HD, Sherwood RA, Nicolaides KH. 1997. Maternal serum free β-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies. Br J Obstet Gynaecol 104: 741-743.
13. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH. 1996. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 7: 421-423.
14. Souter VL, Kapur RP, Nyholt DR, et al. 2003. A report of dizygous monochorionic twins. N Engl J Med 349: 154-158.
15. Spencer K. 2000. Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn 20: 91-95.
16. Taylor MJO, Fisk NM. 2000. Prenatal diagnosis in multiple pregnancy. Baillieres Clin Obstet Gynaecol 14: 663-675.
17. Wald NJ, Densem JW. 1994a. Maternal serum free β-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Prenat Diagn 14: 319-320.
18. Wald NJ, Densem JW. 1994b. Maternal serum free α-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Prenat Diagn 14: 717-719.
19. Wald N, Cuckle H, Wu T, George L. 1991. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Br J Obstet Gynaecol 98: 905-908.
20. Wald NJ, Cuckle HS. 1993. The complementary use of biochemical tests and ultrasonography in the detection of neural tube defects and Down syndrome: part I screening. In Textbook of Ultrasound in Obstetrics and Gynecology, Chervenak FA, Isaacson G, Campbell S (eds). Little Brown & Company: Boston, MA: 1135-1143.
21. Wald NJ, Densem JW, Smith D, Klee GG. 1994. Four-marker serum screening for Down's syndrome. Prenat Diagn 14: 707-716.
22. Wald NJ, George L, Smith D, Densem JW, Petterson K. 1996a. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 103: 407-412.
23. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. 1996b. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16: 143-153.
24. Wald NJ, Kennard A, Hackshaw A, McGuire A. 1997a. Antenatal screening for Down's syndrome. J Med Screen 4: 181-247.
25. Wald NJ, Densem JW, George L, et al. 1997b. Inhibin-A in Down's syndrome pregnancies: revised estimate of standard deviation. Prenat Diagn 17: 285-290.
26. Wald NJ, Rish S, Hackshaw AK. 2003. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. Prenat Diagn 23: 588-592.
27. Watt HC, Wald NJ, George L. 1996. Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome. Prenat Diagn 16: 927-929.